Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting No phase listed Observational Accepts healthy volunteers

SPIROMICS Study of Early COPD Progression (SOURCE)

ClinicalTrials.gov ID: NCT05033990

Public ClinicalTrials.gov record NCT05033990. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 6:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is an observational study of 1000 participants to further define the nature of early chronic obstructive pulmonary disease (COPD) in younger, at-risk individuals. The study has three main goals: * To use CT scan imaging to identify which smokers will develop COPD. * To identify biomarkers predictive of smokers that will develop COPD. * To determine if sputum (phlegm) can be analyzed to predict which smokers will develop COPD. Procedures (methods): All participants will undergo study related questionnaires assessing medical history, smoke exposure and use, medication use, social and behavioral health, pulmonary symptoms, food frequency, and will provide nasal swab, blood, stool, and urine samples, pulmonary function testing to determine function, sputum induction to provide a sputum sample for airway biospecimen analysis, and CT imaging of the lungs.

Study identification

NCT ID
NCT05033990
Recruitment status
Recruiting
Study type
Observational
Phase
Not listed
Enrollment
1,000 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
30 Years to 55 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 7, 2021
Primary completion
Apr 30, 2027
Completion
Apr 30, 2027
Last update posted
Jun 2, 2026

2021 – 2027

United States locations

U.S. sites
14
U.S. states
12
U.S. cities
13
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35205 Recruiting
Mayo Clinic Arizona Scottsdale Arizona 85259 Recruiting
University of California Los Angeles Los Angeles California 90095 Recruiting
University of California, San Francisco San Francisco California 94143 Recruiting
National Jewish Health Denver Colorado 80206 Recruiting
University of Illinois Chicago Chicago Illinois 60608 Recruiting
University of Iowa Iowa City Iowa 52242 Recruiting
Johns Hopkins Bayview Medical Center Baltimore Maryland 21224 Recruiting
University of Michigan Ann Arbor Michigan 48130 Recruiting
Columbia University New York New York 10032 Recruiting
Weill Cornell Medical Center New York New York 10065 Recruiting
Wake Forest Winston-Salem North Carolina 27104 Recruiting
Temple University Philadelphia Pennsylvania 10140 Recruiting
University of Utah Salt Lake City Utah 84108 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05033990, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 2, 2026 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05033990 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →